Adjuverende kemoterapi til patienter med rectumcancer--en gennemgang af et Cochranereview

Camilla Qvortrup, John Pløen Mortensen, Per Pfeiffer

Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

Abstrakt

A new Cochrane meta-analysis evaluated adjuvant chemotherapy (5-fluorouracil (5FU)-based, not modern combination chemotherapy) in almost 10,000 patients with rectal cancer and showed a 17% reduction in mortality corresponding well to the efficacy observed in recent studies, which reported a reduction in mortality just about 20%. The authors recommend adjuvant chemotherapy which is in accordance with the Danish national guidelines where 5-FU-based chemotherapy is recommended for stage III and high-risk stage II rectal cancer.
Bidragets oversatte titelAdjuvant chemotherapy for patients with rectal cancer
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind175
Udgave nummer37
Sider (fra-til)2098-2101
ISSN0041-5782
StatusUdgivet - 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Adjuverende kemoterapi til patienter med rectumcancer--en gennemgang af et Cochranereview'. Sammen danner de et unikt fingeraftryk.

Citationsformater